This ligand trap has been shown to be able to block FGF2-dependent cell proliferation and inhibit the growth of several cancers in xenograft models, including FGFR1-amplified lung cancer and FGF2-overexpressing mesothelioma [216]. This evidence concerns the gene FGF2 and mesothelioma.